{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:50:27Z","timestamp":1790297427813,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jpsychires.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T17:32:22Z","timestamp":1518543142000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment"],"prefix":"10.1016","volume":"102","author":[{"given":"David","family":"Edberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Hoppensteadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8235-3624","authenticated-orcid":false,"given":"Amanda","family":"Walborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawed","family":"Fareed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sinacore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Halaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2018.02.004_bib1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2012.03.033","article-title":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study","volume":"141","author":"Abbasi","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.20589","article-title":"Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial","volume":"26","author":"Akhondzadeh","year":"2009","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2018.02.004_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1192\/bjp.bp.112.122838","article-title":"Pattern recognition analysis of anterior cingulate cortex blood flow to classify depression polarity","volume":"203","author":"Almeida","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.02.004_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bdi.12324","article-title":"Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial","volume":"17","author":"Arabzadeh","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-1781(86)90040-5","article-title":"Depression, immunocompetence, and prostaglandins of the E series","volume":"17","author":"Calabrese","year":"1986","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.iac.2009.02.002","article-title":"Cytokine, sickness behavior, and depression","volume":"29","author":"Dantzer","year":"2009","journal-title":"Immunol. Allergy Clin."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4088\/JCP.14r09007","article-title":"C-reactive protein alterations in bipolar disorder: a meta-analysis","volume":"76","author":"Darg\u00e9l","year":"2015","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jad.2013.04.039","article-title":"Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder","volume":"150","author":"Dickerson","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4088\/JCP.v61n0306","article-title":"Prevalence of overweight and obesity in bipolar patients","volume":"61","author":"Elmslie","year":"2000","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4088\/JCP.08m04309","article-title":"A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method","volume":"70","author":"Fekadu","year":"2009","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4088\/JCP.08m04728","article-title":"The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms","volume":"70","author":"Fekadu","year":"2009","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jad.2012.01.016","article-title":"The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder","volume":"138","author":"Ga\u0142ecki","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib14","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.npbr.2014.01.151","article-title":"Inflammation control reverses treatment-resistance in bipolar depression","volume":"20","author":"Halaris","year":"2014","journal-title":"Neurol. Psychiatr. Brain Res."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpsychires.2015.04.026","article-title":"Does escitalopram reduce neurotoxicity in major depression?","volume":"66\u201367","author":"Halaris","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00124509-200312000-00002","article-title":"Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy","volume":"19","author":"Hestad","year":"2003","journal-title":"J. ECT"},{"key":"10.1016\/j.jpsychires.2018.02.004_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.123.2.365","article-title":"The liver as the site of C-reactive protein formation","volume":"123","author":"Hurlimann","year":"1966","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1084\/jem.148.2.466","article-title":"Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit","volume":"148","author":"Kushner","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2018.02.004_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.biopsych.2003.11.017","article-title":"Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression","volume":"55","author":"Lawrence","year":"2004","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib22","first-page":"891","article-title":"A randomized, double-blind, placebo-controlled trial of celecoxib augmentation of sertraline in treatment of drug-naive depressed women: a pilot study","volume":"14","author":"Majd","year":"2015","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.jpsychires.2018.02.004_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4088\/JCP.v63n0306","article-title":"Correlates of overweight and obesity in 644 patients with bipolar disorder","volume":"63","author":"McElroy","year":"2002","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0006-3223(00)00955-0","article-title":"Altered salivary dehydroepiandrosterone levels in major depression in adults","volume":"48","author":"Michael","year":"2000","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1089\/cap.2016.0207","article-title":"A randomized, double-blind placebo-controlled trial on effectiveness and safety of celecoxib adjunctive therapy in adolescents with acute bipolar mania","volume":"27","author":"Mousavi","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","article-title":"The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine","volume":"11","author":"M\u00fcller","year":"2006","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pnpbp.2013.09.006","article-title":"Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis","volume":"48","author":"Na","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2018.02.004_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Nery","year":"2008","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0006-3223(88)90283-1","article-title":"Increased level of salivary prostaglandins in patients with major depression","volume":"23","author":"Ohishi","year":"1988","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib32","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/15622970802573246","article-title":"Pro-inflammatory biomakers in depression: treatment with venlafaxine","volume":"10","author":"Piletz","year":"2009","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3325\/cmj.2013.54.453","article-title":"Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disorders","volume":"54","author":"Topic","year":"2013","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jad.2011.08.022","article-title":"Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder","volume":"136","author":"Tsai","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib36","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-Reactive protein levels in overweight and obese adults","volume":"282","author":"Visser","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jpsychires.2018.02.004_bib37","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1002\/1529-0131(199912)42:12<2561::AID-ANR8>3.0.CO;2-U","article-title":"Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures","volume":"42","author":"Yaron","year":"1999","journal-title":"Arthritis Rheum."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395617309081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395617309081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T02:51:57Z","timestamp":1575341517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395617309081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":37,"alternative-id":["S0022395617309081"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.02.004","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}